Growth Metrics

Neogenomics (NEO) Long-Term Deferred Tax (2016)

Neogenomics filings provide 3 years of Long-Term Deferred Tax readings, the most recent being $6.5 million for Q4 2016.

  • On a quarterly basis, Long-Term Deferred Tax rose 120.06% to $6.5 million in Q4 2016 year-over-year; TTM through Dec 2016 was $6.5 million, a 120.06% increase, with the full-year FY2016 number at $6.5 million, up 120.06% from a year prior.
  • Long-Term Deferred Tax hit $6.5 million in Q4 2016 for Neogenomics, up from -$32.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $6.5 million in Q4 2016 to a low of -$32.4 million in Q4 2015.
  • Median Long-Term Deferred Tax over the past 3 years was $320000.0 (2014), compared with a mean of -$8.5 million.
  • Biggest five-year swings in Long-Term Deferred Tax: tumbled 10227.81% in 2015 and later skyrocketed 120.06% in 2016.
  • Neogenomics' Long-Term Deferred Tax stood at $320000.0 in 2014, then tumbled by 10227.81% to -$32.4 million in 2015, then surged by 120.06% to $6.5 million in 2016.
  • The last three reported values for Long-Term Deferred Tax were $6.5 million (Q4 2016), -$32.4 million (Q4 2015), and $320000.0 (Q4 2014) per Business Quant data.